Market update: Athabasca Nuclear (ASC.V) loads up on lithium plays

Rolling around the junior markets this morning, there’s considerable activity among many ‘friends of’ such as Veritas.

Veritas Pharmaceuticals (VRT.C) announced this past week it has placed its first orders for research cannabis from Whistler Medical Marijuana in BC. With that announcement came news of the first two targets the group’s team of scientists will be scope-locked on, in Train Wreck and Northern Tonic.

The company is seeking to identify the primo strains to treat nausea, vomiting and pain in patients, and is working with a lethal lineup of professors emeritus (emeritii?) to work through two strains per week until they’ve got enough data for clinical trials.

Medical Jane says of Train Wreck, “genetics consist of Mexican (Sativa), Thai (Sativa), Afghani (Indica), making this strain a Sativa-dominant Hybrid. Predominantly affecting the mind, patients can expect TrainWreck to provide a significant rush of adrenaline, coupled with a calming body buzz.”

It adds, “Trainwreck strain is very popular among patients suffering from ADHD, anxiety, stress, migraines, headaches, PTSD, and chronic aches and pain. Properly grown TrainWreck provides an intense head-high as well as a soothing couch-lock within a few seconds. Some patients swear by Train Wreck, claiming it is the only marijuana strain they medicate with (when it is available at their local dispensary). Additionally, the Trainwreck strain is used by many to help them cope with joint pain and muscle stiffness.”

Sounds like a good first option. On the Whistler website, Northern Tonic is described with the notes, “Effects start early. Aches and pains fade away. Thoughts are slightly random but not scattered. A pleasant mental buzz arrives. […] The physical effects are not narcotic yet pain and inflammation disappear.”

VRT is down slightly from its high period of a few weeks back, but maintaining volume and clearly moving forward as expected.

Also trading on volume is Equitas Resources (EQT.V), which had a soft week last week but has really revved the last few days, moving up from $0.06 to $0.07. That seems to have been the point of max resistance since EQT started bumping its head against it a few weeks back. Should the stock manage to touch $0.08 soon, I’d think we’ll see it break free at last.

I talked to exec Kyler Hardy briefly today from South America, where he’s been looking over the company’s recently acquired Brazilian gold producing operation for the last three weeks, and he said everything is going as expected.

Speaking of Brazil – the lake though, not the country – Ryan Kalt’s Athabasca Nuclear (ASC.V) has been on a property acquisition frenzy of late, culminating in the company’s grabbing of 14.6k hectares of lithium targets over 221 contiguous licenses in Nova Scotia’s Brazil Lake region.

CEO Ryan Kalt said of the deal, “Securing the largest part of the Brazil Lake region for ASC is a significant achievement. Beyond the area already having been identified as hosting one of North America’s richest spodumene lithium occurrences it is also systemically underexplored. This new lithium exploration asset is another excellent addition to our robust and growing lithium project portfolio and we are excited to partake in Nova Scotia’s clean commodity potential.”

Kalt’s been busy of late. After putting out an NI 43-101 on the Preston Uranium Project in February, he’s been prolific in staking new areas featuring gold, diamond, nickel/cobalt and uranium prospects, and recently hit the turbo button on lithium, gaining projects in Quebec, Alberta, Nunavut and the Northwest Territories, and now Nova Scotia. Heck, Kalt’s even testing the tops of spruce trees to see if they have trace metals that may indicate prospects below.

ASC was trading at $0.025 in early March. It’s at $0.085 today and climbing.

Speaking of climbing, Nano One Materials (NNO.V) is a flat out monster this year. Very happy for all Equity.Guru readers who got in when it was in the $0.30’s, back when we first started talking about it. We remain long on this tech play that touches the lithium craze just enough to remain relevant, while its team keeps kicking goals.


— Chris Parry

FULL DISCLOSURE: Veritas, Equitas and Nano One Materials are Equity.Guru clients, and the author owns stock in all three.

Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

Leave a Reply

Be the First to Comment!

Notify of